# Delivery Order #SPE2D326F171Y

Pfizer Delivery Order for Injectable Tranexamic Acid

**Buyer:** Defense Logistics Agency

**Award Amount:** $134.76
**Ceiling:** $134.76

**Awarded:** June 05, 2026
**Period of Performance:** Jun 05, 2026 - Jun 08, 2026

**Identifier:** SPE2D326F171Y
**NAICS:** 325412

This is a short-term delivery order under a broader Department of Defense indefinite delivery vehicle held by Pfizer Inc., a pharmaceutical company. It covers CYKLOKAPRON (tranexamic acid), an injectable medicine supplied in 1,000 mg/10 mL vials, for delivery in New York. The order supports access to an essential medication used to help control bleeding and contributes to military medical supply readiness. It was issued under Pfizer’s existing supply vehicle; the data provided does not identify whether this individual order was competed or sole-source, nor does it provide a justification. The parent vehicle is a long-term arrangement for pharmaceutical manufacturing and distribution and is identified as competitively awarded. The order’s performance period is brief and falls within the parent vehicle’s extended term. No acquisition program, subcontractors, prior related task orders, or original solicitation details are provided.

### Description

4572042654!CYKLOKAPRON 1,000 MG/10 ML VL 10ML

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2D326F171Y_9700_SPE2D020D0014_9700)
